Opens.
Delivers.
Maintains.
- May 2013:Why Intersect ENT is an Example of Hope for the Medtech Industry
- Mar 2013:Sinus “Stent” Helps Patients Breathe Easier
- Jan 2013:Warren Man With Chronic Sinusitus Breathes Easy After Implant Surgery
- Jan 2013:Intersect ENT Initiates U.S. Clinical Study of a Novel In-Office Treatment for Chronic Sinusitis Patients
- May 2013:Why Intersect ENT is an Example of Hope for the Medtech Industry
- Mar 2013:Sinus “Stent” Helps Patients Breathe Easier
- Jan 2013:Warren Man With Chronic Sinusitus Breathes Easy After Implant Surgery
- Jan 2013:Intersect ENT Initiates U.S. Clinical Study of a Novel In-Office Treatment for Chronic Sinusitis Patients
For Patients
PROPEL Steroid-Releasing Implant
Intersect ENT has developed the PROPEL dissolvable sinus implant to improve surgical outcomes for chronic sinusitis sufferers.
PROPEL is the first of a new category of products offering localized, controlled drug delivery directly to the sinus tissue. Inserted by a physician to maintain the surgical opening, the spring-like implant expands to prop open the ethmoid sinus and gradually delivers an advanced corticosteroid with anti-inflammatory properties directly to the sinus lining where it's needed most as the implant dissolves.
The PROPEL system has been clinically proven to prevent obstruction of the ethmoid sinus following surgery. Obstruction can occur due to recurrent scarring and inflammation. The result is improved post-operative outcomes, reducing the need for additional surgical procedures and systemic steroids that can have serious side effects.*
*Patients with chronic sinusitis should consult their ENT surgeon for a full discussion of risks and benefits to determine whether this product is the right choice
Caution: Federal law (USA) restricts this product to sale by or on the order of a physician.
patient story
A chronic sinusitis patient recently featured on NBC news.
see propel in action
Watch a brief video to see how PROPEL opens, delivers, and maintains.
Publications
Kennedy DW.
The PROPEL steroid releasing bioabsorbable implant to improve outcomes of sinus surgery.
Expert Review of Respiratory Medicine. 2012; 6(5):493-498.
Han JK, Marple BF, Smith TL et al.
Effect of steroid-releasing sinus implants on post-operative medical and surgical interventions.
Int Forum Allergy Rhinol. 2012; 2:271-279.